Nanotechnology
Nanoparticles Show Promise in Treating Metabolic Disorders
Researchers at Kyoto University have engineered biodegradable periodic mesoporous organosilica (BPMO) nanoparticles to improve the delivery and efficacy of bezafibrate, a medication used to treat metabolic disorders such as obesity and diabetes. The study found that the nanoparticles successfully restored mitochondrial function and reduced oxidative stress in insulin-resistant cells, offering